The expression level of paraoxonases in cervical dysplastic processes

Levakov S.A., Sheshukova N.A., Obukhova E.A., Antipova N.V., Pavlyukov M.S., Shakhparonov M.I.

1) Department of Obstetrics and Gynecology, Faculty of General Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russia; 2) Academicians M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia
Objective. To study the level of expression of paraoxonases (PONs) in the cervical epithelium of healthy women and that of female patients with cervical dysplastic processes. To comparatively analyze the expression level of PON1, PON2, and PON3 between the groups. To identify the relationship of changes in the level of expression of PONs to the development of cervical dysplastic processes.
Subjects and methods. The investigation covered 47 patients who were divided into 3 groups: 1) 16 patients with CIN I-II; 2) 17 patients with CIN II-III; 3) 14 healthy women. The expression of paraoxonases was analyzed by real-time PCR using primers specific to these genes.
Results. The authors found a significant increase in the expression level of the PON3 gene in the cervical epithelium of women with cervical dysplastic processes compared to the control group. There were no significant differences in the level of PON2 expression between the two groups. PON1 gene expression was unidentified in all the samples.
Conclusion. During the investigation, the authors found a clear relationship between the higher expression of PON3 and the presence of CIN. The findings suggest that the enzyme PON3 may play a role in the development of dysplastic processes; therefore, determination of the level of PON3 expression may possess certain clinical potential in the diagnosis of precancerous cervical diseases. Thus, further researches in this area are required to develop new prognostic markers for the diagnosis of cervical dysplasia and diagnostic markers for the transition of CIN to cancer, which will be able to improve the quality of early diagnosis of precancerous diseases of the cervix and to optimize differentiated treatment policy.

Keywords

paraoxonase 1
2
3
cervical dysplasia
oxidative stress

References

  1. Петрова Г.В. Рак шейки матки. Динамика основных статистических показателей. Иccледования и практика в медицине. 2016; 3 (Спецвыпуск: I Национальный конгресс «Онкология репродуктивных органов: от профилактики и раннего выявления к эффективному лечению» 19-21 мая 2016 года Москва): 134. [Petrova G.V. Cervical cancer. Dynamics of the main statistical indicators. Research and Practical Medicine Journal/Issledovaniya i praktika v meditsine. 2016; 3(Suppl.): 134. (in Russian)]. https://dx.doi.org/10.17709/2409-2231-2016-3-S.
  2. Давыдов М.И., Аксель Е.М., ред. Статистика злокачественных новообразований в России и странах СНГ в 2012 году. М.: Издательская группа РОНЦ; 2014. [Davydov M.I., Aksel’ E.M., eds. Statistika zlokachestvennykh novoobrazovanii v Rossii i stranakh SNG v 2012. Moscow: Izdatel’skaya gruppa RONTs; 2014. (in Russian)].
  3. Наврузова В.С. Анализ результатов хирургического лечения рака шейки матки пациенток фертильного возраста. Опухоли женcкой репродуктивной системы. 2015; 11(3): 87-96. [Navruzova V.S. Results of surgical treatment of cervical cancer patients of childbearing age. Tumors of Female Reproductive System/Opukholi zhenskoy reproduktivnoy sistemy. 2015; 11(3): 87-96. (in Russian)]. https://dx.doi.org/10.17650/1994-4098-2015-11-3-87-96.
  4. Bermudez A., Neerja B., Eric L. Cancer of the cervix uteri. Int. J. Gynaecol. Obstet. 2015. 131(Suppl. 2): S88-95. https://dx.doi.org/10.1016/j.ijgo.2015.06.004.
  5. Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., eds. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 v1.0 IARC CancerBase No. 11. 2012. Available at: http://globocan.iarc.fr
  6. Абакарова П.Р., Прилепская В.Н. ВПЧ-ассоциированные заболевания шейки матки. Возможности комплексной терапии. Гинекология. 2017; 19(5): 4-9. [Abakarova P.R., Prilepskaya V.N. HPV-associated diseases of the cervix. Complex therapy options. Ginecology/Ginekologiya. 2017; 19(5): 4-9. (in Russian)].
  7. Murata M. Inflammation and cancer. Environ. Health Prev. Med. 2018; 23(1): 50. https://dx.doi.org/10.1186/s12199-018-0740-1.
  8. Джалалова П.М., Томилова И.К., Алексахина Е.Л., Лапочкина Н.П. Роль локального оксидативного стресса в патогенезе интраэпителиальной дисплазии и рака шейки матки. Иccледования и практика в медицине. 2016; 3(Спецвыпуск: I Национальный конгресс «Онкология репродуктивных органов: от профилактики и раннего выявления к эффективному лечению» 19–21 мая 2016 года Москва): 68-9. [Dzhalalova P.M., Tomilova P.M., Aeksahina E.L., Lapochkina N.P. The role of local oxidative stress in the pathogenesis of intraepithelial dysplasia and cervical cancer. Research and Practical Medicine Journal/Issledovaniya i praktika v meditsine. 2016; 3(Suppl.): 68-9. (in Russian)]. https://dx.doi.org/10.17709/2409-2231-2016-3-S.
  9. Gupta R.K., Patel A.K., Shah N., Chaudhary A.K., Jha U.K., Yadav U.C. et al. Oxidative stress and antioxidants in disease and cancer: a review. Asian Pac. J. Cancer Prev. 2014; 15(11): 4405-9. https://dx.doi.org/10.7314/apjcp.2014.15.11.4405.
  10. Ebrahimi S., Soltani A., Hashemy S.I. Oxidative stress in cervical cancer pathogenesis and resistance to therapy. J. Cell. Biochem. 2018; Nov 13. https://dx.doi.org/10.1002/jcb.28007
  11. Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 2012; 24(5): 981-90. https://dx.doi.org/10.1016/j.cellsig.2012.01.008.
  12. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002; 82(1): 47-95.
  13. Кормош Н.Г. Физиологическая роль активных форм кислорода (субклеточный уровень) – взгляд клинициста. Российский биотерапевтический журнал. 2011; 10(4): 29-35. [Kormosh N.G. Physiological role of a reactive oxygen species (subcellular level) – clinician viewpoint. Russian Journal of Biotherapy/Rossiiskii bioterapevticheskii zhurnal. 2011; 10(4): 29-35. (in Russian)].
  14. Боровкова Е.И., Антипова Н.В., Корнеенко Т.В., Шахпаронов М.И., Боровков И.М. Параоксоназа: универсальный фактор антиоксидантной защиты организма человека. Вестник Российской академии медицинских наук. 2017; 72(1): 5-10. [Borovkova E.I., Antipova N.V., Korneenko T.V., Shakhparonov M.I., Borovkov I.M.Paraoxonase: the universal factor of antioxidant defense in human body. Annals of the Russian academy of medical sciences/Vestnik Rossiiskoi akademii meditsinskikh nauk. 2017; 72(1): 5-10. (in Russian)].
  15. Ефимцева Э.А., Челпанова Т.И. Параоксоназа: молекулярно-генетические аспекты и клиническое значение. Успехи современной биологии. 2012; 132(3): 282-96. [Efimtseva E.A., Chelpanova T.I. Paraoxonase: molecular genetic aspects and clinical value. Biology Bulletin Reviews/Uspekhi sovremennoi biologii. 2012; 132(3): 282-96. (in Russian)].
  16. Furlong C.E., Marsillach J., Jarvik G.P., Costa L.G. Paraoxonases-1, -2 and -3: What are their functions? Chem. Biol. Interact. 2016; 259(Pt B): 51-62. https://dx.doi.org/10.1016/j.cbi.2016.05.036.

Received 19.11.2019

Accepted 29.11.2019

About the Authors

Sergey Levakov, MD, PhD, professor, head of the Department of Obstetrics and Gynecology, FSAEI HE I.M.Sechenov First MSMU MOH, Russia.
Address: Trubetskaya street 8/2, Moscow, 119991, Russian Federation.
Natalya Sheshukova, MD, PhD, professor of the Department of Obstetrics and Gynecology, FSAEI HE I.M.Sechenov First MSMU MOH, Russia.
Address: 119991, Russian Federation, Moscow, Trubetskaya street 8/2.
Elizaveta Obukhova, graduate student of the Department of Obstetrics and Gynecology, FSAEI HE I.M.Sechenov First MSMU MOH, Russia. Address: Trubetskaya street 8/2, Moscow, 119991, Russian Federation.
Nadezhda Antipova, Candidate of Biological Sciences, researcher of the Shemyakin-Ovchinnikov Institute of bioorganic chemistry of the Russian Academy of Sciences, associate professor of the Department of Pharmaceutical and Toxicological Chemistry of the Peoples’ Friendship University of Russia. Address: 117997, Moscow, GSP-7, ul. Miklukho-Maklaya, d. 16/10.
Marat Pavlyukov, Candidate of Biological Sciences, researcher of the Shemyakin-Ovchinnikov Institute of bioorganic chemistry of the Russian Academy of Sciences. Address: 117997, Russia, Moscow, ul. Miklukho-Maklaya, d. 16/10.
Mikhail Shakhparonov, Doctor of Chemical Sciences, Leading Researcher of the Shemyakin-Ovchinnikov Institute of bioorganic chemistry of the Russian Academy of Sciences.
Address: 117997, Moscow, GSP-7, ul. Miklukho-Maklaya, d. 16/10.

For citation: Levakov S.A., Sheshukova N.A., Obukhova E.A., Antipova N.V., Pavlyukov M.S., Shakhparonov M.I. The expression level of paraoxonases in cervical dysplastic processes.
Akusherstvo i Ginekologiya/ Obstetrics and gynecology. 2020;2:149-53. (In Russian).
https://dx.doi.org/10.18565/aig.2020.2.149-153

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.